Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Medicine, Placebo, Internal medicine, Disease, Clinical trial, and Pittsburgh compound B.
The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis